PLAUR and familial pancreatic carcinoma: Here, we characterized 2 immuno-PET antibodies targeting the human uPAR (huPAR) and murine uPAR (muPAR) forms from commercial sources to address preclinical questions in aging, pancreatic cancer, and chemotherapy-induced senescence.